Chemours Co is 1.6x more valuable than INNOSPEC INC. by market capitalization ($3.31 B vs $2.13 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IOSP | CC |
|---|---|---|
| Market cap | $2.13 B | $3.31 B |
| US-listed rank | #2067 | #1741 |
| Revenue (latest FY) | $1.78B | $5.81B |
| Net income (latest FY) | $119.50M | -$386.00M |
| Net margin | 6.7% | -6.6% |
| P/E (trailing FY) | 17.8 | - |
| SEC filings | 1,749 | 979 |
Chemours Co is 1.6x more valuable than INNOSPEC INC. by market capitalization ($3.31 B vs $2.13 B).
In their latest fiscal years, INNOSPEC INC. reported $1.78B in revenue while Chemours Co reported $5.81B.
Full pages: INNOSPEC INC. and Chemours Co, or browse the full rankings.